CINOXACIN Drug Patent Profile
Which patents cover Cinoxacin, and when can generic versions of Cinoxacin launch?
Cinoxacin is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in CINOXACIN is cinoxacin. There is one drug master file entry for this compound. Additional details are available on the cinoxacin profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CINOXACIN?
- What are the global sales for CINOXACIN?
- What is Average Wholesale Price for CINOXACIN?
Summary for CINOXACIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,640 |
| DailyMed Link: | CINOXACIN at DailyMed |
Recent Clinical Trials for CINOXACIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Louisville | Early Phase 1 |
| James Graham Brown Cancer Center | Early Phase 1 |
| Julio Ramirez | Early Phase 1 |
Medical Subject Heading (MeSH) Categories for CINOXACIN
Anatomical Therapeutic Chemical (ATC) Classes for CINOXACIN
US Patents and Regulatory Information for CINOXACIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | CINOXACIN | cinoxacin | CAPSULE;ORAL | 073005-001 | Feb 28, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | CINOXACIN | cinoxacin | CAPSULE;ORAL | 073006-001 | Feb 28, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
